
Wuxi Yisheng Micro-Nano Medical Technology
Developing solutions for precision medicine.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
* | N/A | Series A | |
Total Funding | 000k |
Related Content
Wuxi Yisheng Micro-Nano Medical Technology, operating under the brand Innosonics, is a high-tech enterprise focused on the precision medicine field. The company's journey began in 2009 as Wuxi Witeng Electronic Technology Co., before being established as Wuxi Innosonics Medical Technology Co., Ltd in 2021, with its headquarters in Wuxi, China. This private company directs its efforts towards the design, research, development, and production of sophisticated ultrasonic transducers. Innosonics operates two specialized factories—a Piezoelectric Intelligent Material Factory and a Transducer Intelligent Manufacturing Factory—along with a dedicated Research and Development Center.
The company's business model is centered on providing advanced ultrasound diagnosis and treatment products to its clients. The product portfolio is extensive, covering three main categories: ultrasound imaging, ultrasonic energy, and industrial & sensing applications. In the medical imaging sector, Innosonics produces miniaturized invasive interventional probes for procedures like intracardiac and intracavitary ultrasound, as well as conventional in-vitro imaging probes. The ultrasonic energy division develops components for therapeutic applications, including ultrasonic scalpels, high-intensity focused ultrasound for tumor treatment, and transducers for physiotherapy and aesthetic procedures like skin tightening and fat dissolving. For industrial markets, the company supplies high-performance materials such as single crystals, polymer piezoelectric materials, and piezoelectric ceramic composites.
Innosonics has established a significant research and innovation hub, attracting talent from top Chinese universities and fostering collaborations with institutions like Peking University and the Shanghai Institute of Silicate Research to advance its technological capabilities. The firm has successfully secured funding from multiple investors, including Co-Win Ventures, Chiron Ventures, Guolian Investment, Qiaojing Capital, and Wuxi Capital, to support its growth and product development.
Keywords: ultrasonic transducers, precision medicine, medical imaging probes, piezoelectric materials, interventional ultrasound, high-intensity focused ultrasound, ultrasonic scalpels, medical technology, diagnostic equipment, physiotherapy transducers, intracardiac ultrasound, in-vitro diagnostics, single crystal materials, polymer piezoelectric, ceramic composites, medical device manufacturing, R&D, life sciences, healthcare technology, surgical instruments, minimally invasive